TransMontaigne Partners L.P. Schedules Conference Call

DENVER--(BUSINESS WIRE)-- TransMontaigne Partners L.P. (NYSE: TLP) today announced that management has scheduled a conference call for Thursday, May 7, 2015 at 11:00 a.m. ET to discuss the Partnership’s results of operations for the three months ended March 31, 2015. TransMontaigne Partners intends to issue an earnings press release before the open of the market on Thursday, May 7, 2015.

CONFERENCE CALL(800) 230-1096Ask For:TransMontaigne Partners

A playback of the conference call will be available from 1:00 p.m. (ET) on Thursday, May 7, 2015 until 11:59 p.m. (ET) on Thursday, May 14, 2015 by calling:

USA: (800) 475-6701International: (320) 365-3844Access Code: 359306

About TransMontaigne Partners L.P.

TransMontaigne Partners L.P. is a terminaling and transportation company based in Denver, Colorado with operations primarily in the United States along the Gulf Coast, in the Midwest, in Houston and Brownsville, Texas, along the Mississippi and Ohio Rivers, and in the Southeast. We provide integrated terminaling, storage, transportation and related services for customers engaged in the distribution and marketing of light refined petroleum products, heavy refined petroleum products, crude oil, chemicals, fertilizers and other liquid products. Light refined products include gasolines, diesel fuels, heating oil and jet fuels; heavy refined products include residual fuel oils and asphalt. We do not purchase or market products that we handle or transport. News and additional information about TransMontaigne Partners L.P. is available on our website: www.transmontaignepartners.com.

TransMontaigne Partners L.P.
Frederick W. Boutin, CEO, 303-626-8200
Gregory J. Pound, COO, 303-626-8200
Robert T. Fuller, CFO, 303-626-8200

Source: TransMontaigne Partners L.P.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders
• Metropolitan Law Group Warns Minnesota Homeowners: Transfer on Death Deeds May Trigger Estate Recovery Investigations